2015 Strategic Assessments of Current and Emerging Tumor Marker Testings Market Players
This new 80-page report from VPGMarketResearch.com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include:
- Sales
- Product portfolios
- Distribution tactics
- Technological know-how
- New products in R&D
- Collaborative arrangements
- Business strategies.
Abbott
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Gen-Probe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
More Publications
2015 Strategies in the French Hospital Tumor Marker Testing Market
US$ 3,080.00
February 2015
533 pages
2015 Strategies in the German Hospital Tumor Marker Testing Market
US$ 3,080.00
February 2015
530 pages
2015 Strategies in the Italian Hospital Tumor Marker Testing Market
US$ 3,080.00
February 2015
525 pages
2015 Strategies in the Japanese Hospital Tumor Marker Testing Market
US$ 3,880.00
February 2015
537 pages
2015 Strategies in the Spanish Hospital Tumor Marker Testing Market
US$ 3,080.00
February 2015
521 pages
